Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Pouillart

Showing results (31-40 of 320) with videos related to

Pageof 32
Sort By:
Presse Medicale (Paris, France : 1983)|December 2, 1995
[Important chemosensitivity of extraneural metastases of oligodendroglioma]P Beuzeboc, R Dhote, B Christoforov, et al.
Pathologie-Biologie|November 1, 1992
[Imaging of malignant bone tumors: impact of new imaging techniques on treatment methods]L Ollivier, P Pouillart, B Tomeno, et al.
Pathologie-Biologie|September 1, 1978
[Serum beta2-microglobulin and carcino-embryonic antigen in cancerous patients. A preliminary study of 258 cases (author's transl)]P Pouillart, H Magdelenat, T Palangie, et al.
La Revue Du Praticien|April 1, 1992
[Ewing's tumor]P Pouillart, X Sastre, L Ollivier, et al.
The Journal of Infusional Chemotherapy|January 1, 1995
Combined chemotherapy and irradiation for transitional cell cancer of the bladder: a reviewP Beuzeboc, D Pontvert, P Pouillart, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Interleukin-2 therapy for metastatic uveal melanomaT Dorval, W H Fridman, C Mathiot, et al.
The British Journal of Cancer. Supplement|March 1, 1975
Cytology in the classification of diffuse non-leukaemic malignant lymphomata (lympho- and reticulosarcomata)G Mathé, P Pouillart, J R Schlumberger, et al.
Bulletin Du Cancer|December 1, 1995
[Chemotherapy of metastatic endometrial carcinoma. Review of the literature]J Y Pierga, V Dieras, D Paraiso, et al.
British Journal of Cancer|December 1, 1977
Intense tumour-cell destruction by syngeneic mice: role of macrophages, complement activation and tumour-cell factorsS Orbach-Arbouys, J Lheritier, M Allouche, et al.
Bulletin Du Cancer|January 1, 1974
[Cytology in classification of non-leukemic diffuse cancerous lymphomas (Lympho- and reticulosarcomas)]G Mathé, P Pouillart, J R Schlumberger, et al.
Pageof 32

Showing results (31-40 of 320) with videos related to

Sort By:
Pageof 32
Presse Medicale (Paris, France : 1983)|December 2, 1995
[Important chemosensitivity of extraneural metastases of oligodendroglioma]P Beuzeboc, R Dhote, B Christoforov, et al.
Pathologie-Biologie|November 1, 1992
[Imaging of malignant bone tumors: impact of new imaging techniques on treatment methods]L Ollivier, P Pouillart, B Tomeno, et al.
Pathologie-Biologie|September 1, 1978
[Serum beta2-microglobulin and carcino-embryonic antigen in cancerous patients. A preliminary study of 258 cases (author's transl)]P Pouillart, H Magdelenat, T Palangie, et al.
La Revue Du Praticien|April 1, 1992
[Ewing's tumor]P Pouillart, X Sastre, L Ollivier, et al.
The Journal of Infusional Chemotherapy|January 1, 1995
Combined chemotherapy and irradiation for transitional cell cancer of the bladder: a reviewP Beuzeboc, D Pontvert, P Pouillart, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Interleukin-2 therapy for metastatic uveal melanomaT Dorval, W H Fridman, C Mathiot, et al.
The British Journal of Cancer. Supplement|March 1, 1975
Cytology in the classification of diffuse non-leukaemic malignant lymphomata (lympho- and reticulosarcomata)G Mathé, P Pouillart, J R Schlumberger, et al.
Bulletin Du Cancer|December 1, 1995
[Chemotherapy of metastatic endometrial carcinoma. Review of the literature]J Y Pierga, V Dieras, D Paraiso, et al.
British Journal of Cancer|December 1, 1977
Intense tumour-cell destruction by syngeneic mice: role of macrophages, complement activation and tumour-cell factorsS Orbach-Arbouys, J Lheritier, M Allouche, et al.
Bulletin Du Cancer|January 1, 1974
[Cytology in classification of non-leukemic diffuse cancerous lymphomas (Lympho- and reticulosarcomas)]G Mathé, P Pouillart, J R Schlumberger, et al.
Pageof 32